Optomed Oyj - Major shareholder announcements

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed Plc         Stock Exchange Release    9 April 2021 at 11.00, Helsinki

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding
change in holdings

Optomed Plc (“Optomed” or the “Company”) has received a notification in
accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act
(as amended, the “SMA”) from OP-Rahastoyhtiö Oy (“OP-Rahastoyhtiö”). According
to the notification, the total holdings in Optomed shares and votes held by OP
-Rahastoyhtiö has increased to 5.46 per cent of all of the registered shares in
Optomed on 8 April 2021.

The total number of the Company’s registered shares amounts to 14,003,144
shares. Each share entitles to one vote.

The total position of OP-Rahastoyhtiö subject to the notification:

                  % of        % of shares and voting rights         Total of
                  shares and  through financial instruments (total  both in %
                  voting      of B)                                 (A+B)
                  rights
                  (total
                  of A)
Resulting             5.46 %                                     -     5.46 %
situation on the
date on
which threshold
was crossed or
reached
Position of           4.99 %                                     -     4.99 %
previous
notification
(if applicable)

Notified details of the resulting situation on the date on which the threshold
was crossed or reached:

A: Shares and voting rights

Class/type of  Number               % of shares and voting rights
sharesISIN     of
code           shares
               and
               voting
               rights
Direct         Indirect  Direct     Indirect
(SMA 9:5)      (SMA 9:6  (SMA 9:5)  (SMA 9:6 ja 9:7)
               ja 9:7)
FI4000410881    764,744          -            5.46 %            -
SUBTOTAL A                 764,744                        5.46 %%

Information in relation to the person subject to the notification obligation as
contained in the notification

The complete chain of controlled undertakings through which the shares, voting
rights and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity:

Name                % of shares  % of shares and voting rights  Total
                    and voting   through financial instruments  of
                    rights                                      both
OP-Rahastoyhtiö Oy            -                              -      -
OP-Suomi                   3.05                              -   3.05
Mikroyhtiöt
-sijoitusrahasto
OP-Suomi                   2.41                              -   2.41
Pienyhtiöt
-sijoitusrahasto

Further enquiries

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com, +358(0)50 562
4077.

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld screening devices fundus
cameras with software and artificial intelligence with the aim to transform the
diagnostic process of blinding eye-diseases such as rapidly increasing diabetic
retinopathy. In its business Optomed focuses on eye-screening devices and
software solutions related R&D in Finland and sales through different channels
in over 60 countries. The company has an extensive portfolio of 565
international patents protecting the technology.